Rat Aortic Endothelial Cells (RAOEC) monolayer (L) and labeled with DiI-Ac-LDL (red), the acetylated apoprotein specifically recognized by endothelial cell receptors (R).
Rat Aortic Endothelial Cells: RAOEC
Rat Aortic Endothelial Cells (RAOEC) are primary macrovascular cells isolated from the inner endothelial lining (tunica intima) of healthy rat (Rattus norvegicus) aorta tissue.
Description
Rat Aortic Endothelial Cells (RAOEC) are primary macrovascular cells isolated from the inner endothelial lining (tunica intima) of healthy rat ( Rattus norvegicus ) aorta tissue. In cell culture, these rat primary cells form a contact-inhibited, monolayer-forming cell population structurally characterized by a typical cobblestone morphology at confluence. Unlike immortalized cells or continuous cell lines, primary RAOEC preserve native physiological signaling cascades, intact receptor baselines, and accurate mechanosensitive responses.
To maintain their phenotypic stability, prevent premature senescence, and avoid non-endothelial contamination, they must be maintained in optimized Rat Endothelial Cell Growth Medium . Quality control validation for these cell biologics products requires rigorous screening for acetylated-LDL uptake, alongside negative selection for non-endothelial markers. Standard screening protocols also mandate routine testing to ensure cultures are free of contaminants like mycoplasma, verifying their cellular morphology and expression profiles against appropriate endothelial reference cells rather than unrelated cell lines.
In the living organism, these vascular endothelial cells form the continuous, macrovascular inner barrier of the aorta — which serves as the primary conduit elastic artery of the systemic arterial tree. RAOEC reside at the critical interface between the blood vessel wall and the circulating bloodstream. They rest upon a subendothelial basement membrane, directly overlying the internal elastic lamina and the vascular smooth muscle cells of the tunica media. While microvascular endothelial cell networks in specific organs exhibit highly specialized barrier properties — such as the tight junctions of brain endothelial cells forming the blood-brain barrier — macrovascular RAOEC are optimized to withstand high pulsatile pressures and transduce systemic mechanical forces.
The primary biological function of RAOEC is to act as a semi-permeable physical, metabolic, and immunoregulatory barrier that governs macromolecular transport and dictates arterial tone. These cells utilize endothelial nitric oxide synthase (eNOS) to produce nitric oxide (NO), a critical vasorelaxant that regulates smooth muscle relaxation and maintains an anti-thrombotic, thromboresistant state. However, chronic mechanical stress, metabolic disturbances, or inflammatory cytokines disrupt this homeostatic balance, precipitating endothelial dysfunction.
While uniform laminar fluid shear stress promotes cell survival and suppresses apoptosis, irregular or disturbed flow profiles (such as those occurring at arterial curves or bifurcations) trigger an active inflammatory response. This biomechanical activation leads to increased paracellular permeability, structural realignment away from the direction of blood flow, and the upregulated expression of cell surface adhesion molecules — such as VCAM-1, ICAM-1, and E-selectin. This molecular activation coordinates the tethering, rolling, and transendothelial migration of peripheral immune cells into the subendothelial space, driving the progression of localized cardiovascular diseases, hypertension, and atherosclerosis.
In cell biology, molecular biology, and discovery pharmacology, RAOEC serve as a premier rodent in vitro platform for preclinical cardiovascular research. While human primary aortic endothelial cells (HAOEC) remain the preferred standard for human-relevant translational work, investigators leverage RAOEC to bridge findings between in vitro mechanobiology and in vivo rat tissues or mouse tissues, routinely comparing outcomes against mouse endothelial cells, rabbit cells, or human aortic endothelial cells (HAOEC). However, researchers must account for the distinct limitations of cross-species extrapolation, including species-specific differences in receptor sequences, signaling kinetics, and drug responses.
Researchers deploy these primary cells within specialized parallel-plate flow chambers or cone-and-plate shear systems to analyze mechanotransduction pathways, track endpoints like apoptosis or surface marker shifts via flow cytometry during in vitro models mimicking ischemia-reperfusion (such as hypoxia/reoxygenation or simulated flow interruption), and utilize techniques like endothelial specific adenoviral overexpression to precisely map targeted intracellular kinase cascades. Furthermore, RAOEC function as a crucial tool in tumor endothelial cell culture and angiogenesis research, where investigators employ them in scratch-wound migration and tube-formation assays to screen candidate anti-angiogenic small molecules or test protective therapeutics engineered to mitigate oxidative damage without inducing unwanted cytotoxicity. To accommodate complex experimental designs, specialized cell culture services are available to provide custom cell isolation protocols and custom cell lots, supplying researchers with highly validated, non-immortalized human primary cells or animal-derived primary cells tailored to replicate intricate macrovascular microenvironments.
Rat Aortic Endothelial Cells (RAOEC)Â provide an excellent model system to study all aspects of cardiovascular function and disease, and they have been utilized in dozens of research publications. The cells test positive for DiI-Ac-LDL uptake.
Details
| Tissue: | Normal healthy adult rat aorta | |
|---|---|---|
| QC | No bacteria, yeast, fungi, mycoplasma | |
| Character | Positive for DiI-Ac-LDL uptake | |
| Bioassay | Attach, spread, proliferate in Growth Med | |
| Cryovial | 500,000 RAOEC (3rd passage) frozen in basal medium w/ 10% FBS, 10% DMSO | |
| Kit | Cryovial frozen RAOEC (R304-05a), Gr Med (R211-500), Attch Fct Sol (123-100), Subcltr Rgnt Kit (090K) | |
| Proliferating | Shipped in Gr Med, 4th psg (flasks or plates) | |
| Doublings | At least 6 | |
| Applications | Laboratory research use only (RUO). Not for human, clinical, diagnostic or veterinary use. |
Resources
FAQs
Need More Help?
Visit our comprehensive FAQ page for detailed answers to common questions.
Need More Help?
Visit our comprehensive FAQ page for detailed answers to common questions.
Primary Cell FAQs
Powered by Bioz